节点文献

灵芝多糖对HepG2细胞诱导的肝癌小鼠肠道菌群及其菌群代谢功能的调节作用

Regulation of intestinal floras and their metabolism functions by ganoderma lucidum plysaceharide in mice with HepG2 cell-induced implanted cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 于雷孙超张曼旭

【Author】 Yu Lei;Sun Chao;Zhang Manxu;120 Emergency Rescue Center,Tongzhou;

【机构】 北京市通州区120紧急救援中心包头医学院第二附属医院普通外科

【摘要】 目的研究灵芝多糖对Hep G2细胞诱导的肝癌小鼠肠道菌群及其菌群代谢功能的调节作用。方法采用Hep G2细胞构建肝癌小鼠模型,将21只造模成功的肝癌小鼠随机分为模型组、灵芝多糖(GLP)和益生菌处理组,每组7只,另选择正常小鼠7只作为对照组,给予药物处理组动物GLP或益生菌灌胃,另两组采用生理盐水灌胃,连续干预2 w。采用镜检法和变性梯度凝胶电泳法(DGGE)检测小鼠肠道菌群结构、多样性及其脂肪酸代谢产物水平。结果肝癌小鼠肠道双歧杆菌、乳酸杆菌、大肠埃希菌和肠球菌数量分别为(2.3±0.5)×1010CFU/g、(12.2±2.2)×109CFU/g、(3.9±1.5)×107CFU/g和(5.0±1.2)×1010CFU/g,显著高于对照组[分别为(0.94±0.18)×1010CFU/g、(3.49±0.66)×109CFU/g、(1.12±0.11)×107CFU/g和(0.57±0.06)×1010CFU/g,P<0.05],GLP干预组小鼠肠道上述菌群分别为(1.1±0.1)×1010CFU/g、(6.5±1.1)×109CFU/g、(1.8±0.2)×107CFU/g和(1.5±0.1)×1010CFU/g,均显著低于模型组(P<0.05);GLP处理组小鼠肠道菌群丰富度、多样性指数和均匀度分别为(7.2±1.1) S、(4.8±1.1) H和(1.0±0.2) E,显著高于模型组【分别为(5.7±1.2) S、(3.4±0.5) H、(0.7±0.1) E,P<0.05】;GLP干预组小鼠肠道菌群乙酸、丙酸、正丁酸和D-乳酸水平分别为(37.9±3.3) mmol/L、(3.9±0.2) mmol/L、(2.3±0.3) mmol/L和(0.2±0.0) g/L,与模型组【分别为(26.8±3.2) mmol/L、(1.8±0.4) mmol/L、(1.8±0.2) mmol/L和(0.5±0.1) g/L比,差异显著(P<0.05)。结论肝癌小鼠肠道菌群出现了失调,而应用GLP可能帮助改善机体肠道微生态紊乱状态,其意义还有待探讨。

【Abstract】 Objective The aim of this experimental study was to implore the regulation of intestinal floras and their metabolism functions by ganoderma lucidum plysaceharide( GLP) in mice with HepG2 cell-induced implanted cancer. Methods The subcutaneous cancer in mice was established by HepG2 cell implantation,and 21 mice with successful implanted cancer were randomly divided into model,GLP-intervened and probiotics-intervened groups,with 7 in each. 7 normal mice were selected as control. The GLP and probiotics were administered intragastrically,while normal saline were given by gavage in model and control for 2 weeks. The diversity of intestinal floras,and fatty acid metabolites were detected by microscopy and denaturing gradient gel electrophoresis( DGGE). Results The number of Bifidobacterium,Lactobacillus,Escherichia Coli and Enterococcus in model group were( 2.3± 0. 5) × 1010 CFU/g,( 12. 2 ± 2. 2) × 109 CFU/g,( 3. 9 ± 1. 5) × 107 CFU/g and( 5. 0 ± 1. 2) × 1010 CFU/g,all significantly higher than [( 0.94±0.18) ×1010 CFU/g,( 3.49± 0.66) × 109 CFU/g,( 1.12± 0.11) × 107 CFU/g and( 0.57± 0.06) ×1010 CFU/g,respectively,P<0.05]in the control,ylajj@ 163.com while they were( 1.1±0.1) ×1010 CFU/g,( 6.5±1.1) ×109 CFU/g,( 1.8±0.2) ×107 CFU/g and( 1.5±0.1) ×1010 CFU/g in GLP-intervened group( P<0.05); the abundance,the diversity index and uniformity of intestinal floras in GLP-intervened group were( 7.2 ± 1.1) S,( 4.8 ± 1.1) H and( 1. 0 ± 0. 2) E,all significantly higher than [( 5.7±1.2) S,( 3.4±0.5) H and( 0.7±0.1) E,respectively,P<0.05] in the model; the intestinal flora acetic acid,propionic acid and n-butyric acid in GLP-intervened group were( 37.9±3.3) mmol/L,( 3.9±0.2) mmol/L and( 2.3±0.3) mmol/L,all significantly higher than [( 26. 8 ± 3. 2) mmol/L,( 1. 8 ± 0. 4)mmol/L and( 1.8±0.2) mmol/L,respectively,P< 0.05],while the D-lactic acid was( 0.2±0.0) g/L,much lower than( 0.5±0.1) g/L in the model( P<0.05). Conclusion The imbalance of intestinal floras is closely related to the carcinogenesis in mice,and the GLP administration might correct the intestinal microecological disorders,which warrants further investigation.

【基金】 北京市自然科学基金资助项目(编号:20198485)
  • 【文献出处】 实用肝脏病杂志 ,Journal of Practical Hepatology , 编辑部邮箱 ,2021年04期
  • 【分类号】R285.5
  • 【被引频次】2
  • 【下载频次】651
节点文献中: 

本文链接的文献网络图示:

本文的引文网络